Skip to main content
SCYNEXIS INC logo

SCYNEXIS INC — Investor Relations & Filings

Ticker · SCYX ISIN · US8112922005 LEI · 529900XBHFGMNTU70154 US Manufacturing
Open in API
Filings indexed 684 across all filing types
Latest filing 2014-04-30 Regulatory Filings
Country US United States of America
Listing US SCYX

About SCYNEXIS INC

https://www.scynexis.com/

SCYNEXIS, Inc. is a biotechnology company focused on the discovery and development of novel anti-infectives to overcome difficult-to-treat and drug-resistant fungal infections. The company is pioneering a new class of broad-spectrum antifungal agents called 'fungerps,' which are triterpenoid-based compounds. These agents are being developed in both oral and intravenous formulations to treat a range of serious, invasive, and life-threatening fungal diseases, particularly those encountered in hospital environments. SCYNEXIS aims to address the significant global health threat of antifungal resistance by providing innovative therapeutic options where existing treatments are limited or ineffective. The company's development pipeline includes second-generation fungerp candidates.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2014
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC Division of Corporation Finance regarding a Registration Statement on Form S-1 for SCYNEXIS, Inc. It is a request for acceleration of the effective date of the registration statement under Rule 461 of the Securities Act. The letter also provides information about the distribution of preliminary prospectuses and compliance with Rule 15c2-8. This is a regulatory communication related to the registration and offering process, not a financial report, earnings release, or other report type. The document is short (1961 characters) and is a formal regulatory filing related to securities offering procedures. Therefore, it fits best under Regulatory Filings (RNS).
2014-04-30 English
Regulatory Filings 2014
Regulatory Filings Classification · 95% confidence The document is a letter from SCYNEXIS, Inc. to the U.S. Securities and Exchange Commission requesting acceleration of effectiveness for a Registration Statement on Form S-1. It is a formal request related to the registration process for securities, specifically under Rule 461 of the Securities Act of 1933. The document does not contain financial statements, earnings data, or detailed report content. It is a procedural filing related to the registration process rather than a financial report or announcement of results. Given the nature and length (2720 characters), it is not a full report but a regulatory filing related to securities registration. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2014-04-30 English
AMENDMENT NO. 3 TO FORM S-1
Capital/Financing Update Classification · 95% confidence The document is an Amendment No. 3 to Form S-1 Registration Statement filed with the SEC by SCYNEXIS, Inc. It is a registration statement under the Securities Act of 1933, used for initial public offerings or other securities offerings. The text includes detailed information about the offering, risk factors, management discussion, financial data, and underwriting details. This is not a financial report like an annual or quarterly report, nor is it an earnings release or a proxy statement. It is a capital markets filing related to the registration of securities for public sale. The closest fitting category from the provided list is Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities, including registration statements for securities offerings.
2014-04-30 English
Capital/Financing Update 2014
Capital/Financing Update Classification · 95% confidence The document is a correspondence letter addressed to the SEC Division of Corporation Finance regarding a Registration Statement on Form S-1 for SCYNEXIS, Inc. It discusses the request for acceleration of effectiveness of the registration statement and details about distribution of preliminary prospectuses to underwriters and investors. This is related to the process of a securities offering and does not contain financial statements or report data. It is a regulatory communication related to capital raising but not a report or announcement of financial results. Given the content and context, this fits best under Capital/Financing Update (CAP) as it pertains to the registration and offering process for securities.
2014-04-25 English
Regulatory Filings 2014
Regulatory Filings Classification · 100% confidence The document is a letter addressed to the U.S. Securities and Exchange Commission requesting acceleration of effectiveness for a Registration Statement on Form S-1. It references Rule 461 under the Securities Act of 1933 and discusses procedural matters related to the registration statement becoming effective. There is no financial data, report content, or detailed disclosures typical of an Annual Report, Interim Report, or other financial filings. The document is a formal regulatory correspondence related to the registration process, not a report or announcement of financial results. Given the short length (2704 characters) and the nature of the content, this fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory communications that do not fit other categories.
2014-04-25 English
FWP
Capital/Financing Update Classification · 95% confidence The document is an Issuer Free Writing Prospectus (FWP) filed pursuant to Rule 433, relating to a preliminary prospectus and registration statement for an initial public offering (IPO) of common stock by SCYNEXIS, Inc. It contains detailed information about the offering, including number of shares, price range, dilution, risk factors, and capital requirements. This type of document is a capital markets disclosure related to fundraising and securities issuance. It is not a financial report, earnings release, or management discussion. It is specifically a prospectus supplement or free writing prospectus related to capital raising. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is sufficient and contains substantive information about the offering, not just an announcement or link to a report.
2014-04-02 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.